Ocumension Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Ocumension Therapeutics has a total shareholder equity of CN¥2.9B and total debt of CN¥120.0M, which brings its debt-to-equity ratio to 4.1%. Its total assets and total liabilities are CN¥3.3B and CN¥351.0M respectively.
Key information
4.1%
Debt to equity ratio
CN¥120.00m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.05b |
Equity | CN¥2.92b |
Total liabilities | CN¥351.03m |
Total assets | CN¥3.27b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1477's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥315.3M).
Long Term Liabilities: 1477's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥35.7M).
Debt to Equity History and Analysis
Debt Level: 1477 has more cash than its total debt.
Reducing Debt: 1477 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1477 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1477 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.